title: Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network.
abstract: BACKGROUND
  Protein-protein interaction networks and phenotype similarity information have been synthesized together to discover novel disease-causing genes. Genetic or phenotypic similarities are manifested as certain modularity properties in a phenotype-gene heterogeneous network consisting of the phenotype-phenotype similarity network, protein-protein interaction network and gene-disease association network. However, the quantitative analysis of modularity in the heterogeneous network and its influence on disease-gene discovery are still unaddressed. Furthermore, the genetic correspondence of the disease subtypes can be identified by marking the genes and phenotypes in the phenotype-gene network. We present a novel network inference method to measure the network modularity, and in particular to suggest the subtypes of diseases based on the heterogeneous network.
  
  
  RESULTS
  Based on a measure which is introduced to evaluate the closeness between two nodes in the phenotype-gene heterogeneous network, we developed a Hitting-Time-based method, CIPHER-HIT, for assessing the modularity of disease gene predictions and credibly prioritizing disease-causing genes, and then identifying the genetic modules corresponding to potential subtypes of the queried phenotype. The CIPHER-HIT is free to rely on any preset parameters. We found that when taking into account the modularity levels, the CIPHER-HIT method can significantly improve the performance of disease gene predictions, which demonstrates modularity is one of the key features for credible inference of disease genes on the phenotype-gene heterogeneous network. By applying the CIPHER-HIT to the subtype analysis of Breast cancer, we found that the prioritized genes can be divided into two sub-modules, one contains the members of the Fanconi anemia gene family, and the other contains a reported protein complex MRE11/RAD50/NBN.
  
  
  CONCLUSIONS
  The phenotype-gene heterogeneous network contains abundant information for not only disease genes discovery but also disease subtypes detection. The CIPHER-HIT method presented here is effective for network inference, particularly on credible prediction of disease genes and the subtype analysis of diseases, for example Breast cancer. This method provides a promising way to analyze heterogeneous biological networks, both globally and locally.
authors: MOE Key Laboratory of Bioinformatics and Bioinformatics Division, Tsinghua National Laboratory for Information Science and Technology, Tsinghua University, Beijing 100084, China.
authors: Xin
authors: X
authors: Yao
authors: Han
authors: H
authors: Hao
authors: Yanda
authors: Y
authors: Li
authors: Shao
authors: S
authors: Li
references: Nat Clin Pract Oncol. 2007 Sep;4(9):516-25
references: 17728710
references: Physiol Genomics. 2003 Nov 11;15(3):223-7
references: 12966136
references: Cancer. 2007 May 1;109(9):1721-8
references: 17387718
references: FEBS Lett. 2008 Jul 23;582(17):2549-54
references: 18582463
references: PLoS One. 2009 May 20;4(5):e5624
references: 19462000
references: PLoS Genet. 2010 Jul 01;6(7):e1001012
references: 20617168
references: Nat Rev Genet. 2004 Jul;5(7):545-51
references: 15211356
references: Nat Biotechnol. 2007 Mar;25(3):309-16
references: 17344885
references: Nat Genet. 2010 May;42(5):368-9
references: 20428093
references: PLoS Comput Biol. 2006 Dec 29;2(12):e174
references: 17196032
references: Nat Commun. 2010 Jul 13;1:34
references: 20975711
references: Nature. 2008 Apr 3;452(7187):564-70
references: 18385730
references: Nature. 2000 Feb 3;403(6769):503-11
references: 10676951
references: Bioinformatics. 2006 Nov 15;22(22):2800-5
references: 16954137
references: Mol Syst Biol. 2008;4:189
references: 18463613
references: Pac Symp Biocomput. 2007;:28-39
references: 17992743
references: Mol Cancer Ther. 2009 Mar;8(3):672-81
references: 19276159
references: Mol Cell. 2004 Sep 24;15(6):853-65
references: 15383276
references: Cancer Res. 2003 Nov 1;63(21):7167-75
references: 14612510
references: Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2024-32
references: 17932350
references: Hum Genet. 2008 Aug;124(1):19-29
references: 18551320
references: Nucleic Acids Res. 2006;34(19):e130
references: 17020920
references: Mol Syst Biol. 2007;3:88
references: 17353930
references: Breast Cancer Res Treat. 2008 Nov;112(1):89-98
references: 18049890
references: Breast Cancer Res Treat. 2008 Oct;111(3):481-7
references: 17975727
references: Genome Res. 2003 Oct;13(10):2363-71
references: 14525934
references: N Engl J Med. 2010 May 20;362(20):1909-19
references: 20484397
references: Cell. 2006 May 19;125(4):801-14
references: 16713569
references: Bioinformatics. 2007 Aug 15;23(16):2129-38
references: 17553855
references: Am J Hum Genet. 2008 Apr;82(4):949-58
references: 18371930
references: Bioinformatics. 2010 May 1;26(9):1219-24
references: 20215462
references: Eur J Hum Genet. 2006 May;14(5):535-42
references: 16493445
references: IET Syst Biol. 2007 Jan;1(1):51-60
references: 17370429
references: Brief Bioinform. 2007 Sep;8(5):333-46
references: 17638813
references: PLoS One. 2010 Jul 26;5(7):e11764
references: 20668676
references: J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61
references: 16145046
references: J Med Genet. 2006 Aug;43(8):691-8
references: 16611749